Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
Abstract Introduction Biological drugs (BD) and Janus kinase inhibitors (JAKi) have revolutionized the treatment of diverse dermatoses. However, there are concerns regarding their safety, especially the risk of cancer and opportunistic infections. Here, we discuss the risk of cancer associated with...
Kaydedildi:
Asıl Yazarlar: | , |
---|---|
Materyal Türü: | Kitap |
Baskı/Yayın Bilgisi: |
Adis, Springer Healthcare,
2024-05-01T00:00:00Z.
|
Konular: | |
Online Erişim: | Connect to this object online. |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Internet
Connect to this object online.3rd Floor Main Library
Yer Numarası: |
A1234.567 |
---|---|
Kopya Bilgisi 1 | Kütüphanede |